RXRX - Recursion Pharmaceuticals, Inc.
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$5.50
DETAILS
HIGH:
$5.50
LOW:
$5.50
MEDIAN:
$5.50
CONSENSUS:
$5.50
UPSIDE:
66.16%
Institutional Holders (13F)
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-07-07 | Borgeson Blake | director | SELL | 40,000 | $3.96 | $158K |
| 2026-07-01 | Dar Zavain | director | A-Award | 5,109 | -- | -- |
| 2026-07-01 | Li Dean Y | director | A-Award | 3,747 | -- | -- |
| 2026-06-17 | Dar Zavain | director | A-Award | 88,424 | -- | -- |
| 2026-06-17 | Bumpus Namandje | director | A-Award | 88,424 | -- | -- |
| 2026-06-18 | Bumpus Namandje | director | SELL | 3,963 | $3.18 | $13K |
| 2026-06-17 | Li Dean Y | director | A-Award | 88,424 | -- | -- |
| 2026-06-17 | Michor Franziska | director | A-Award | 88,424 | -- | -- |
| 2026-06-17 | Borgeson Blake | director | A-Award | 88,424 | -- | -- |
| 2026-06-17 | HERSHBERG ROBERT | director | A-Award | 88,424 | -- | -- |
| 2026-06-17 | Sun Elaine D | director | A-Award | 88,424 | -- | -- |
| 2026-06-15 | Taylor Ben R | officer: Chief Financial Officer | F-InKind | 5,396 | $3.15 | $17K |
| 2026-06-05 | Khan Najat | director, officer: CEO and President | SELL | 23,588 | $3.58 | $84K |
| 2026-06-05 | Gibson Christopher | director | C-Conversion | 40,000 | -- | -- |
| 2026-06-05 | Gibson Christopher | director | SELL | 40,000 | $3.62 | $145K |
| 2026-06-02 | Borgeson Blake | director | SELL | 30,000 | $3.68 | $110K |
| 2026-06-03 | Bumpus Namandje | director | SELL | 4,386 | $3.54 | $16K |
| 2026-05-22 | Gibson Christopher | director | C-Conversion | 40,000 | -- | -- |
| 2026-05-22 | Gibson Christopher | director | SELL | 40,000 | $3.08 | $123K |
| 2026-05-15 | Hallett David | officer: Chief Scientific Officer | F-InKind | 26,657 | $3.04 | $81K |
| 2026-05-15 | Khan Najat | director, officer: CEO and President | F-InKind | 62,701 | $3.04 | $191K |
| 2026-05-15 | Taylor Ben R | officer: Chief Financial Officer | F-InKind | 25,018 | $3.04 | $76K |
| 2026-05-15 | Gibson Christopher | director | F-InKind | 22,821 | $3.04 | $69K |
| 2026-05-07 | Gibson Christopher | director | SELL | 40,000 | $3.37 | $135K |
| 2026-05-07 | Gibson Christopher | director | G-Gift | 20,000 | -- | -- |